Literature DB >> 11790336

'Rings' of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere.

M D Rosenblum1, R R Shivers.   

Abstract

The anti-cancer taxoids, Taxol (paclitaxel) and Taxotere (docetaxel), are the most promising anti-mitotic agents developed for cancer treatment in the past decade. The effectiveness of this new class of compounds lies in their unique mechanism of action on the cytoskeleton. Both taxol and taxotere bind to microtubules and shift the normal equilibrium between monomeric and polymerized tubulin to favor the polymerized form by strongly promoting tubulin assembly and inhibiting microtubule depolymerization. Although very similar in structure, these two compounds have recently demonstrated different in vitro, in vivo, and clinical activities; however, no study to date has effectively compared specific cytoskeletal alterations induced by taxol and taxotere in cultured cells. Using specific staining techniques for both F-actin and alpha-tubulin, this study provides the first detailed immunohistochemical comparison of the effects of equimolar concentrations of taxol and taxotere on both the microfilament and microtubule networks in a cultured cell line. Using human MCF7 breast adenocarcinoma cells, new observations of taxotere/taxol alterations of the cytoskeleton include: an increased abundance of parallel microtubule 'bundles' in taxotere treated cells and a definitive reorganization of the microfilament network which results in novel ring-like formations of F-actin condensed exclusively in the perinuclear zone. Reorganization of the actin cytoskeleton induced by a taxoid disruption of the microtubule equilibrium is indicative of the interdependence between microtubules and microfilaments in this transformed cell line and suggests that the indirect role of the taxoids on the microfilament network may have been overlooked in their mechanism of action as chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11790336     DOI: 10.1016/s0742-8413(99)00101-2

Source DB:  PubMed          Journal:  Comp Biochem Physiol C Toxicol Pharmacol        ISSN: 1532-0456            Impact factor:   3.228


  8 in total

1.  Ionic imbalance, in addition to molecular crowding, abates cytoskeletal dynamics and vesicle motility during hypertonic stress.

Authors:  Paula Nunes; Isabelle Roth; Paolo Meda; Eric Féraille; Dennis Brown; Udo Hasler
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-04       Impact factor: 11.205

2.  Artemin Reduces Sensitivity to Doxorubicin and Paclitaxel in Endometrial Carcinoma Cells through Specific Regulation of CD24.

Authors:  Vijay Pandey; Yewon Jung; Jian Kang; Michael Steiner; Peng-Xu Qian; Arindam Banerjee; Murray D Mitchell; Zheng-Sheng Wu; Tao Zhu; Dong-Xu Liu; Peter E Lobie
Journal:  Transl Oncol       Date:  2010-08-01       Impact factor: 4.243

3.  Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery.

Authors:  Michael C Cochran; John Eisenbrey; Richard O Ouma; Michael Soulen; Margaret A Wheatley
Journal:  Int J Pharm       Date:  2011-05-13       Impact factor: 5.875

4.  Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy.

Authors:  Marcella L B Carneiro; Eloiza S Nunes; Raphael C A Peixoto; Ricardo G S Oliveira; Luiza H M Lourenço; Izabel C R da Silva; Andreza R Simioni; Antônio C Tedesco; Aparecido R de Souza; Zulmira G M Lacava; Sônia N Báo
Journal:  J Nanobiotechnology       Date:  2011-03-28       Impact factor: 10.435

5.  Cellular Interactome Dynamics during Paclitaxel Treatment.

Authors:  Juan D Chavez; Andrew Keller; Bo Zhou; Rong Tian; James E Bruce
Journal:  Cell Rep       Date:  2019-11-19       Impact factor: 9.423

6.  QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model.

Authors:  Jessica Kalra; Corinna Warburton; Karen Fang; Lincoln Edwards; Tim Daynard; Dawn Waterhouse; Wieslawa Dragowska; Brent W Sutherland; Shoukat Dedhar; Karen Gelmon; Marcel Bally
Journal:  Breast Cancer Res       Date:  2009-05-01       Impact factor: 6.466

7.  Cinnamic acid induces apoptotic cell death and cytoskeleton disruption in human melanoma cells.

Authors:  Evandro Luís de Oliveira Niero; Gláucia Maria Machado-Santelli
Journal:  J Exp Clin Cancer Res       Date:  2013-05-23

8.  Rhein Derivative 4F Inhibits the Malignant Phenotype of Breast Cancer by Downregulating Rac1 Protein.

Authors:  Xinxiao Li; Yunfeng Liu; Yuhua Zhao; Wei Tian; Lina Zhai; Huifeng Pang; Jiankang Kang; Huaxin Hou; Yanhua Chen; Danrong Li
Journal:  Front Pharmacol       Date:  2020-05-28       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.